Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prediction of pre‐eclampsia in twin pregnancy by maternal factors and biomarkers at 11–13 weeks' gestation: data from EVENTS trial

3 Nov 2020

Abstract excerpt

ABSTRACT Objectives First, to validate a previously developed model for screening for pre‐eclampsia (PE) by maternal characteristics and medical history in twin pregnancies; second, to compare the distributions of mean arterial pressure (MAP), uterine artery pulsatility index (UtA‐PI), serum placental growth factor (PlGF) and serum pregnancy‐associated plasma protein‐A (PAPP‐A) in twin pregnancies that delivered...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Assisted Reproductive Technology and Twin Pregnancy
Share to Pregnancy and preeclampsia studies
Share to Preterm Birth and Chorioamnionitis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33142361
DOI: 10.1002/uog.23531

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prediction of pre‐eclampsia in twin pregnancy by maternal factors and biomarkers at 11–13 weeks' gestation: data from EVENTS trialPMID 33142361Read ↗

First‐trimester maternal serum pregnancy‐associated plasma protein‐A and pre‐eclampsiaSemantic proximity Read ↗

Non-invasive prediction of preeclampsia using the maternal plasma cell-free DNA profile and clinical risk factorsSemantic proximity Read ↗

Screening for pre‐eclampsia with competing‐risks model using placental growth factor measurement in blood samples collected before 11 weeks' gestationSemantic proximity Read ↗

Development and validation of an interpretable longitudinal preeclampsia risk prediction using machine learningSemantic proximity Read ↗

First-trimester screening with specific algorithms for early- and late-onset fetal growth restrictionSemantic proximity Read ↗

A New Model for Screening for Late-Onset Preeclampsia in the Third TrimesterSemantic proximity Read ↗

Prediction of preterm pre‐eclampsia according to NICE and ACOG criteria: descriptive study of 597 492 Danish births from 2008 to 2017Semantic proximity Read ↗

Dense phenotyping from electronic health records enables machine-learning-based prediction of preterm birthSemantic proximity Read ↗

Comparison of screening for pre-eclampsia at 31-34 weeks' gestation by sFlt-1/PlGF ratio and a method combining maternal factors with sFlt-1 and PlGFSemantic proximity Read ↗

The Prediction of Adverse Maternal Outcomes in PreeclampsiaSemantic proximity Read ↗

Reviewing Accuracy of First Trimester Screening for Preeclampsia Using Maternal Factors and BiomarkersSemantic proximity Read ↗

Differential Predictability of Preterm Birth Types: Strong Signals for Indicated Cases versus Limited Success in Spontaneous Preterm BirthSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.